Targeting ALK: Precision Medicine

Anaplastic Lymphoma Kinase (ALK) is an oncogene frequently found as a fusions in non-small cell lung cancer (NSCLC), as EML4-ALK. Precision medicine uses therapeutic agents that target specific mutations, such as those found in ALK-positive NSCLC patients. Discover the latest research on Targeting ALK here.

April 16, 2021

Hematopoietic Stem Cell Transplantation in T-cell and NK-cell lymphomas-Update on Recent Advances.

Transplantation and Cellular Therapy
Yang Liang Boo, Liang Piu Koh
April 16, 2021
Case Report
Open Access

Successful management of a lung cancer patient harbouring both EGFR mutation and EML4-ALK fusion gene with disseminated intravascular coagulation.

Respiratory Medicine Case Reports
Kohei FujitaTadashi Mio
April 16, 2021
Open Access

Intratumoral Treatment with Chemotherapy and Immunotherapy for NSCLC with EBUS-TBNA 19G.

Journal of Cancer
Paul ZarogoulidisChrisanthi Karapantzou
April 14, 2021
Open Access

Towards a new WHO classification of renal cell tumor: what the clinician needs to know-a narrative review.

Translational Andrology and Urology
Alessia CimadamoreHolger Moch
April 14, 2021

Crizotinib for c-MET-amplified advanced NSCLC: a single-center experience.

Seher Yildiz TacarDeniz Tural
April 14, 2021
Open Access

Clinical application of a lung cancer organoid (tumoroid) culture system.

NPJ Precision Oncology
Etsuko YokotaTomoki Yamatsuji
April 14, 2021

Recent Trend for EGFR-Based and ALK-Based Targets: A Patent Analysis.

Recent Patents on Anti-cancer Drug Discovery
Hai-Long Zhang, Yiqian Li
April 14, 2021
Open Access

Kinase-mediated RAS signaling via membraneless cytoplasmic protein granules.

Asmin TulpuleTrever G Bivona
April 12, 2021

Are all ALK variants created equal? Clinicopathologic features and outcomes: a propensity-matched study.

International Journal of Clinical Oncology
Ullas BatraAnurag Mehta
April 6, 2021

Conditional survival and hazards of death for peripheral T-cell lymphomas.

Hongye GaoYuqin Song
April 6, 2021

Next generation sequencing detection in archival surgically resected lung adenocarcinoma specimens harbouring the anaplastic lymphoma kinase fusion protein.

JPMA. the Journal of the Pakistan Medical Association
Zhiming JiangHongyang Lu

Sign up to follow this feed and discover related papers.

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Biosensors for Cancer Detection

Biosensors are devices that are designed to detect a specific biological analyte by essentially converting a biological entity (ie, protein, DNA, RNA) into an electrical signal that can be detected and analyzed. The use of biosensors in cancer detection and monitoring holds vast potential. Biosensors can be designed to detect emerging cancer biomarkers and to determine drug effectiveness at various target sites. Biosensor technology has the potential to provide fast and accurate detection, reliable imaging of cancer cells, and monitoring of angiogenesis and cancer metastasis, and the ability to determine the effectiveness of anticancer chemotherapy agents.

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.

CAR-T cells

Chimeric antigen receptor (CAR) T cells are cells that are genetically engineered to recognize and target specific proteins. The ability of these cells to recognize cancer antigens and eliminate tumor cells have transformed cancer immunotherapy approaches. Here is the latest research on CAR-T cells.

Cancer -Omics

A variety of different high-throughput technologies can be used to identify the complete catalog of changes that characterize the molecular profile of cohorts of tumor samples. Discover the latest insights gained from cancer 'omics' in this feed.

Cancer Cell Invasion: Nanomedicine

Nanomedicine is a promising alternative for cancer detection and therapy that utilizes nanoparticles, such as liposomes. Nanoparticles can potentially target cancer cell invasion and metastasis. Discover the latest research on Cancer Cell Invasion: Nanomedicine here.

Cancer Disparities

Cancer disparities refers to differences in cancer outcomes (e.g., number of cancer cases, related health complications) across population groups.

Cancer Immunotherapy

Cancer immunotherapy is an important field of research that is looking at controlling cancer and tumor growth by activating the individuals own immune system. Recent studies have utilized chimeric antigen receptor t-cell therapy, immune checkpoint inhibitors and neoantigen vaccines. Discover the latest research on cancer immunotherapy here.

Cancer Incidence & Mortality

Cancer has emerged as a global concern due to its increase in incidence and mortality. Efforts are underway to evaluate and develop action plans to reduce the global burden of cancer. Currently, lung cancer, breast cancer and prostate cancer are the leading causes of cancer mortality. Here is the latest research on cancer incidence and mortality.

Cancer Metabolic Reprogramming

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

© 2021 Meta ULC. All rights reserved